Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - azacitidine 100 mg - powder for suspension for injection - azacitidine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - azacitidine 100 mg - powder for suspension for injection - azacitidine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - azacitidine 100 mg - powder for suspension for injection - azacitidine

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - azacitidine -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine ans is indicated for the treatment of patients with:,? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),,? chronic myelomonocytic leukaemia [cmmol (10-29 percent marrow blasts without myeloproliferative disorder)],,? acute myeloid leukaemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who),,in whom allogenic stem cell transplantation is not indicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine lws is indicated for the treatment of patients with:,? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),,? chronic myelomonocytic leukaemia [cmmol (10-29 percent marrow blasts without myeloproliferative disorder)],,? acute myeloid leukaemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who),,in whom allogenic stem cell transplantation is not indicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine sxp is indicated for the treatment of patients with:,? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),,? chronic myelomonocytic leukaemia [cmmol (10-29 percent marrow blasts without myeloproliferative disorder)],,? acute myeloid leukaemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who),,in whom allogenic stem cell transplantation is not indicated.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

les laboratories neapolis pharma, tunisia - azacitidine - lyophilisate for solution for injection - 100 mg,

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

ohara pharmaceutical co.,ltd. - azacitidine - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

ohara pharmaceutical co.,ltd. - azacitidine - injection